Ominike Marvis in Bayelsa, Nigeria, took her 6-month-old son for a malaria vaccine as part of Nigeria’s campaign to prevent severe illnesses and deaths from the disease. Africa has the highest burden of malaria, with Nigeria accounting for a quarter of cases. The vaccine, developed by Oxford University, is over 75% effective and is seen as a monumental step in Nigeria’s efforts to eliminate malaria, despite challenges like poor sanitation and limited resources.
Full Article





